Medtronic ROE 2006-2019 | MDT

Current and historical return on equity (ROE) values for Medtronic (MDT) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. Medtronic ROE for the three months ending April 30, 2019 was 14.16%.
Medtronic ROE - Return on Equity Historical Data
Date TTM Net Income Shareholder's Equity Return on Equity
2019-04-30 $4.63B $50.21B 9.25%
2019-01-31 $4.92B $49.94B 9.80%
2018-10-31 $2.26B $49.71B 4.49%
2018-07-31 $3.16B $50.33B 6.23%
2018-04-30 $3.10B $50.82B 6.10%
2018-01-31 $2.81B $50.34B 5.53%
2017-10-31 $5.02B $51.58B 9.93%
2017-07-31 $4.12B $50.79B 8.19%
2017-04-30 $4.03B $50.33B 8.02%
2017-01-31 $3.97B $49.49B 7.83%
2016-10-31 $4.24B $50.29B 8.32%
2016-07-31 $3.65B $50.89B 7.08%
2016-04-30 $3.54B $52.06B 6.81%
2016-01-31 $2.43B $50.82B 4.66%
2015-10-31 $2.32B $52.27B 5.19%
2015-07-31 $2.62B $52.81B 7.21%
2015-04-30 $2.68B $53.23B 9.55%
2015-01-31 $3.12B $20.17B 15.96%
2014-10-31 $2.91B $19.44B 15.02%
2014-07-31 $2.98B $19.25B 15.54%
2014-04-30 $3.07B $19.44B 16.12%
2014-01-31 $3.59B $19.35B 19.05%
2013-10-31 $3.81B $18.74B 20.67%
2013-07-31 $3.56B $18.52B 19.70%
2013-04-30 $3.47B $18.67B 19.55%
2013-01-31 $3.49B $17.84B 20.11%
2012-10-31 $3.44B $17.18B 20.00%
2012-07-31 $3.66B $17.26B 21.44%
2012-04-30 $3.62B $17.11B 21.48%
2012-01-31 $3.40B $17.17B 20.56%
2011-10-31 $3.39B $16.74B 21.07%
2011-07-31 $3.09B $16.34B 19.76%
2011-04-30 $3.10B $15.97B 20.38%
2011-01-31 $3.28B $15.36B 22.05%
2010-10-31 $3.18B $14.83B 21.80%
2010-07-31 $3.48B $14.60B 24.38%
2010-04-30 $3.10B $14.63B 22.25%
2010-01-31 $2.25B $14.32B 16.56%
2009-10-31 $2.11B $13.61B 15.95%
2009-07-31 $1.79B $13.14B 13.78%
2009-04-30 $2.07B $13.18B 16.20%
2009-01-31 $2.69B $13.06B 21.74%
2008-10-31 $2.07B $12.62B 17.46%
2008-07-31 $2.19B $12.24B 18.92%
2008-04-30 $2.14B $11.54B 18.95%
2008-01-31 $2.23B $10.97B 20.02%
2007-10-31 $2.86B $11.48B 25.69%
2007-07-31 $2.88B $11.14B 26.54%
2007-04-30 $2.80B $10.98B 26.60%
2007-01-31 $2.73B $10.98B 26.93%
2006-10-31 $2.69B $10.28B 26.05%
2006-07-31 $2.83B $9.90B 26.81%
2006-04-30 $2.55B $9.38B 23.78%
2006-01-31 $2.00B $11.74B 18.25%
2005-10-31 $1.88B $11.13B 17.71%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $133.110B $30.557B
Medtronic Public Limited Company, headquartered in Dublin, Ireland, is among the world's largest medical technology, services and solutions companies - alleviating pain, restoring health and extending life for millions of people around the world. The company is focused on collaborating with stakeholders around the world to take healthcare Further, Together.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $148.050B 28.74
Stryker (SYK) United States $77.009B 27.48
Boston Scientific (BSX) United States $58.755B 28.17
Baxter (BAX) United States $41.655B 26.25
EssilorLuxottica Societe Anonyme (ESLOY) France $29.025B 0.00
Coloplast (CLPBY) Denmark $25.553B 40.79
Zimmer Biomet Holdings (ZBH) United States $24.699B 15.87
Lonza Group Ag (LZAGY) Switzerland $24.641B 0.00
Terumo (TRUMY) Japan $23.393B 26.90
Smith & Nephew SNATS (SNN) United Kingdom $19.003B 0.00
ResMed (RMD) United States $17.837B 34.08
Sunny Optical Technology (SNPTF) China $12.027B 0.00
Canopy Growth (CGC) Canada $11.829B 0.00
Bio-Rad Laboratories (BIO) United States $9.215B 48.85
William Demant Holdings (WILYY) Denmark $7.651B 0.00
Insulet (PODD) United States $7.176B 522.83
Perrigo (PRGO) Ireland $7.039B 11.90
Hill-Rom Holdings (HRC) United States $6.945B 21.06
Aurora Cannabis (ACB) Canada $6.865B 67.70
GN STORE NORD (GNNDY) Denmark $6.409B 32.73
Haemonetics (HAE) United States $6.279B 51.26
GW Pharmaceuticals (GWPH) United Kingdom $5.201B 0.00
ICU Medical (ICUI) United States $5.129B 30.60
Neogen (NEOG) United States $3.284B 53.39
NuVasive (NUVA) United States $2.961B 24.18
Hutchison China MediTech (HCM) China $2.957B 0.00
Agios Pharmaceuticals (AGIO) United States $2.654B 0.00
National Vision Holdings (EYE) United States $2.458B 52.37
Quidel (QDEL) United States $2.284B 23.70
Aphria (APHA) $1.561B 0.00
Cardiovascular Systems (CSII) United States $1.537B 882.60
Phibro Animal Health (PAHC) United States $1.234B 18.49
AtriCure (ATRC) United States $1.212B 0.00
VAREX IMAGING (VREX) United States $1.174B 24.92
Lantheus Holdings (LNTH) United States $1.078B 28.62
NanoString Technologies (NSTG) United States $1.036B 0.00
PetIQ (PETQ) United States $0.971B 23.59
MacroGenics (MGNX) United States $0.775B 0.00
Omeros (OMER) United States $0.770B 0.00
Cerus (CERS) United States $0.759B 0.00
Eagle Pharmaceuticals (EGRX) United States $0.755B 21.17
Quanterix (QTRX) United States $0.742B 0.00
TG Therapeutics (TGTX) United States $0.704B 0.00
LeMaitre Vascular (LMAT) United States $0.574B 27.78
Surmodics (SRDX) United States $0.544B 79.10
OraSure Technologies (OSUR) United States $0.532B 24.51
Meridian Bioscience (VIVO) United States $0.487B 14.90
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.392B 0.00
Vapotherm (VAPO) United States $0.354B 0.00
Utah Medical Products (UTMD) United States $0.321B 22.26
BioLife Solutions (BLFS) United States $0.318B 99.59
Zynex (ZYXI) United States $0.277B 28.53
Bovie Medical (APYX) United States $0.237B 0.00
Cytosorbents (CTSO) United States $0.227B 0.00
Owens & Minor (OMI) United States $0.200B 4.24
Chimerix (CMRX) United States $0.188B 0.00
Rockwell Medical (RMTI) United States $0.175B 0.00
United Health Products (UEEC) United States $0.171B 0.00
Female Health (VERU) United States $0.145B 0.00
Fonar (FONR) United States $0.139B 7.30
Chembio Diagnostics (CEMI) United States $0.098B 0.00
United-Guardian (UG) United States $0.093B 20.56
Surface Oncology (SURF) United States $0.074B 0.00
Trinity Biotech (TRIB) Ireland $0.058B 20.00
Oramed Pharmaceuticals (ORMP) United States $0.057B 0.00